[go: up one dir, main page]

MX2016012903A - Metodos y composiciones para la modificacion de la percepcion sensorial. - Google Patents

Metodos y composiciones para la modificacion de la percepcion sensorial.

Info

Publication number
MX2016012903A
MX2016012903A MX2016012903A MX2016012903A MX2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A MX 2016012903 A MX2016012903 A MX 2016012903A
Authority
MX
Mexico
Prior art keywords
screening
trpa1v1
trp channels
trpv1
compositions
Prior art date
Application number
MX2016012903A
Other languages
English (en)
Inventor
Lin Yakang
Tatachar Sreekrishna Koti
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2016012903A publication Critical patent/MX2016012903A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Compuestos y métodos para modificar la percepción sensorial asociada con los receptores sensoriales transitorios TRPA1, TRPV1 y TRPA1V1. Un método para analizar compuestos para la modulación de TRPA1, TRPV1 y/o TRPA1V1. Composiciones que comprenden agonistas o antagonistas de TRPA1V1, para modificar la percepción sensorial de las composiciones.
MX2016012903A 2014-04-01 2015-03-24 Metodos y composiciones para la modificacion de la percepcion sensorial. MX2016012903A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461973566P 2014-04-01 2014-04-01
PCT/US2015/022170 WO2015153184A1 (en) 2014-04-01 2015-03-24 Method for screening trp channels

Publications (1)

Publication Number Publication Date
MX2016012903A true MX2016012903A (es) 2016-12-07

Family

ID=52815337

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012903A MX2016012903A (es) 2014-04-01 2015-03-24 Metodos y composiciones para la modificacion de la percepcion sensorial.

Country Status (6)

Country Link
US (3) US9427415B2 (es)
EP (1) EP3126831A1 (es)
CN (1) CN106537149A (es)
CA (2) CA2941903A1 (es)
MX (1) MX2016012903A (es)
WO (1) WO2015153184A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018007441A (es) * 2015-12-18 2018-11-09 Procter & Gamble Sintesis de derivados de ester de ciclohexano utiles como agentes de percepcion en productos de consumo.
EP3515215B1 (en) * 2016-09-23 2025-06-11 Sentiens, LLC Agents for modulating the sensory impact of tobacco or herbal smoke
CA3037094C (en) 2016-10-25 2021-12-28 The Procter & Gamble Company Fibrous structures
WO2018081189A1 (en) 2016-10-25 2018-05-03 The Procter & Gamble Company Fibrous structures
CN106822096A (zh) * 2017-01-22 2017-06-13 新乡医学院 治疗动脉粥样硬化的药物组合物以及该药物组合物的应用
WO2021019373A1 (en) * 2019-07-31 2021-02-04 Sea4Us - Biotecnologia E Recursos Marinhos, Lda. Nitenin analogue compounds and their use in the treatment of chronic and acute pain
AU2020337307A1 (en) * 2019-08-30 2022-03-03 Asahi Group Holdings, Ltd. Lipid metabolism promoter
AU2023292000A1 (en) * 2022-06-12 2024-12-19 Buzzelet Development And Technologies Ltd. Modulation of a physiological function via modulation of activation of a transient receptor potential channel receptor
KR20240163321A (ko) * 2023-05-10 2024-11-19 한양대학교 산학협력단 실시간 니코틴 검출 바이오센서용 구조체, 이를 포함하는 바이오센서 및 바이오센서를 이용한 타액에서의 실시간 니코틴 분석 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0211205A (ja) * 1988-06-29 1990-01-16 Kawasaki Steel Corp 熱間圧延機の板厚制御方法
AU742391B2 (en) 1997-08-20 2002-01-03 Regents Of The University Of California, The Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
US6482611B1 (en) 1999-09-23 2002-11-19 Neurogen Corporation Human capsaicin receptor and uses thereof
AU1607701A (en) * 1999-11-15 2001-05-30 J. Manheimer, Inc. Flavor freshness enhancers
US6780443B1 (en) * 2000-02-04 2004-08-24 Takasago International Corporation Sensate composition imparting initial sensation upon contact
US6455278B1 (en) 2000-02-08 2002-09-24 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding human vanilloid receptor VR3
MXPA03001627A (es) 2000-09-02 2003-06-24 Gruenenthal Gmbh Oligonucletodiso antisentido contra vr1.
DE10257421A1 (de) 2002-12-09 2004-07-08 Grünenthal GmbH Regulatorische Elemente im 5'-Bereich des VR1-Gens
US7465581B2 (en) 2002-12-18 2008-12-16 The Scripps Research Institute ANKTM1, a cold-activated TRP-like channel expressed in nociceptive neurons
WO2005087807A1 (en) 2004-03-09 2005-09-22 Renovis, Inc. Vr1 receptors and uses thereof
MX2008010712A (es) * 2006-02-21 2008-11-14 Irm Llc Metodos y composiciones para tratar hiperalgesia.
US7897358B2 (en) * 2007-03-07 2011-03-01 Janssen Pharmaceutica N.V. Canine transient receptor potential V2 (cTRPV2) and methods of screening for TRPV2 channel modulators
CN102149327A (zh) * 2008-07-11 2011-08-10 Sru生物系统公司 鉴定离子通道调节剂的方法
US8962057B2 (en) 2009-04-29 2015-02-24 The Procter & Gamble Company Methods for improving taste and oral care compositions with improved taste
DE102009027744A1 (de) * 2009-07-15 2011-01-20 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Prekursor-Verbindungen von Süßrezeptor-Antagonisten zur Prävention oder Behandlung von Krankheiten
US9044429B2 (en) 2010-01-15 2015-06-02 The Gillette Company Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof
JP5669421B2 (ja) * 2010-03-30 2015-02-12 株式会社マンダム アルコール刺激抑制物質の評価方法
US20130315843A1 (en) * 2012-05-25 2013-11-28 The Procter & Gamble Company Composition for reduction of trpa1 and trpv1 sensations

Also Published As

Publication number Publication date
WO2015153184A8 (en) 2016-12-22
US9427415B2 (en) 2016-08-30
CA3017423A1 (en) 2015-10-08
EP3126831A1 (en) 2017-02-08
US20150272907A1 (en) 2015-10-01
CA2941903A1 (en) 2015-10-08
US20180049960A1 (en) 2018-02-22
CN106537149A (zh) 2017-03-22
US20160331659A1 (en) 2016-11-17
WO2015153184A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
MX2016012903A (es) Metodos y composiciones para la modificacion de la percepcion sensorial.
HUS2500023I1 (hu) Vegyületek és készítmények EGFR mutáns kináz aktivitás modulására
EP3134102A4 (en) Superagonists, partial agonists and antagonists of interleukin-2
ZA201804688B (en) New substituted cyanoindoline derivatives as nik inhibitors
HUE065807T2 (hu) TREM-1 ellenanyagok helyspecifikus mutagenezise viszkozitás csökkentésére
IL275139A (en) NKG2D DARIC receptors
IL257503B (en) Compounds containing a six-membered aza-heterocyclic ring that modulate the opioid-delta receptor, methods for their use and preparation
EP3178536A4 (en) Defoamer oil compound, production method therefor, and defoamer composition
PL3310762T3 (pl) Nowi antagoniści 5-ht2
EP3454845A4 (en) ADRENO RECEPTOR MODULATING CONNECTIONS AND METHOD FOR USE THEREOF
IL271808A (en) Novel mutated azaindoline derivatives as NIK inhibitors
IL248807B (en) Kv1.3 potassium channel antagonists
GB202001915D0 (en) Skive cut borehole screen end ring
ZA201907964B (en) Method of increasing alpha-olefin content
MX2017006032A (es) Composicion y metodo para reducir la viscosidad de petroleo pesado.
PL3621950T3 (pl) Związki stanowiące modulator trpv1
HK40039208A (en) Nkg2d daric receptors
HK40011272A (en) Screening methods using olfactory receptors and novel compounds identified using the same
HK40006193A (en) Adrenergic receptor modulating compounds and methods of using the same
HK1231870A1 (en) Azaspiro derivatives as trpm8 antagonists